Practices and opinions regarding HPV vaccination among French general practitioners: Evaluation through two cross-sectional studies in 2007 and 2010

International Journal of Public Health

Volumn 59, Issue 3, 2014, Pages 519-528

  Lasset, Christine ^a,b   Kalecinski, Julie ^c   Régnier, Véronique ^c   Barone, Giovanna ^a   Leocmach, Yann ^d   Vanhems, Philippe ^b,e   Chauvin, Franck ^c   Lutringer Magnin, Delphine ^a,b  

^a LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d SANOFI PASTEUR   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

Attitude; Evolution; General practitioner; HPV vaccination; Opinion; Practice

Indexed keywords

WART VIRUS VACCINE;

AGE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; PAPILLOMAVIRUS INFECTIONS; PATIENT ATTITUDE; PSYCHOLOGY; SEX DIFFERENCE;

AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FEMALE; GENERAL PRACTITIONERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RESIDENCE CHARACTERISTICS; SEX FACTORS;

EID: 84901285874     PISSN: 16618556     EISSN: 1420911X     Source Type: Journal    
DOI: 10.1007/s00038-014-0555-9     Document Type: Article

References (40)

1. Agius PA, Pitts MK, Smith AM, Mitchell A (2010) Human papillomavirus and cervical cancer: Gardasil vaccination status and knowledge amongst a nationally representative sample of Australian secondary school students. Vaccine 28:4416-4422
2. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377:2085-2092
3. Creswell JW, Plano Clark VL (2007) Designing and conducting mixed methods research. Sage Publications, Thousand Oaks
4. Daley MF, Crane LA, Markowitz LE, Black SR, Beaty BL, Barrow J et al (2010) Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 126:425-433
5. Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, et al. (2013) Reasons for not vaccinating adolescents: national immunization survey of teens, 2008-2010. Pediatrics 131:645-651
6. De Carvalho NS, Teixeira LM, Pradel EM, Gabardo J, Joly C, Urbanetz AA (2009) Vaccinating against HPV: physicians' and medical students' point of view. Vaccine 27:2637-2640
7. Demarteau N, Detournay B, Tehard B, El Hasnaoui A, Standaert B (2011) A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer. Int J Public Health 56:153-162
8. Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H et al (2011) Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 11:39-44
9. Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al. (2010) The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surv 15(47)
10. European Centre for Disease prevention and Control (2012) ECDC guidance, introduction of HPV vaccines in European Union countries - an update. pp 19
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2011) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
12. Forster AS, Marlow LA, Wardle J, Stephenson J, Waller J (2010) Understanding adolescents' intentions to have the HPV vaccine. Vaccine 28:1673-1676
13. Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, Jacquard AC, Régnier V et al (2012) French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14-18 year old daughters: a quantitative-qualitative study. BMC Public Health 12:1034
14. ® et à la stratégie de prévention globale des cancers du col de l'utérus à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23 ans (HPV vaccination recommendations from the « Haut Conseil de la santé publique » in France). Available: http://www.hcsp.fr/docspdf/avisrapports/hcspa20111021-gardasil.pdf http://www.fncgm.com/images/Actualites-medicales-scientifiques/ vaccin-pap-hcsp-12-2010.pdf. Accessed 22 February 2013
15. Hopkins TG, Wood NJ, West RM, Darling JC (2009) UK health professionals' attitudes and knowledge regarding Human Papillomavirus (HPV) vaccination: a West Yorkshire Study. J Paediatr Child Health 45:652-655
16. Institut de Veille Sanitaire (2012) Projection de l'incidence et de la mortalité par cancer en France en 2011: col de l'utérus. Available: http://invs.sante.fr. Accessed 30 January 2013
17. Jeannot E, Sudre P, Chastonay P (2012) HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland. Int J Public Health 57:629-632
18. Jensen ME, Hartenbach E, McElroy JA, Faerber A, Havighurst T, Kim KM et al (2009) Brief report: measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine. WMJ 108:203-205
19. Jim CC, Lee JW, Groom AV, Espey DK, Saraiya M, Holve S et al (2012) Human papillomavirus vaccination practices among providers in Indian health service, tribal and urban Indian healthcare facilities. J Womens Health 21:372-378
20. Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ et al (2009) Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 18:2325-2332
21. Kempe A, Daley MF, McCauley MM, Crane LA, Suh CA, Kennedy AM et al (2011) Prevalence of parental concerns about childhood vaccines: the experience of primary care physicians. Am J Prev Med 40:548-555
22. Ko EM, Missmer S, Johnson NR (2010) Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 14:339-345
23. Krupp K, Marlow LA, Kielmann K, Doddaiah N, Mysore S, Reingold AL et al (2010) Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India. J Adolesc Health 46:379-384
24. Leib S, Liberatos P, Edwards K (2011) Pediatricians' experience with and response to parental vaccine safety concerns and vaccine refusals: a survey of Connecticut pediatricians. Public Health Rep 126(Suppl 2):13-23
25. Lu B, Kumar A, Castellsagué X, Giuliano AR (2011) Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review and meta-analysis. BMC Infect Dis 11:13
26. Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC et al (2011) Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine 29:5322-5328
27. Marlow LA, Wardle J, Forster AS, Waller J (2009) Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Commun Health 63:1010-1015
28. McCave EL (2010) Influential factors in HPV vaccination uptake among providers in four states. J Commun Health 35:645-652
29. Miles MB, Huberman MA (2003) Analyse des données qualitatives. De Boeck, Bruxelles, p 2
30. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527
31. Pélissier G, Bastides F (2008) Vaccination anti-HPV dans le cadre de la prévention du cancer du col de l'utérus en médecine générale. Rev Prat 58:25-31
32. Perkins RB, Clark JA (2012) What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions. Womens Health Issues 22:e378-e379
33. Piana L, Noel G, Uters M, Laporte R, Minodier P (2009) Standpoint and practice concerning the human Papillomavirus vaccine among French family physicians. Med Mal Infect 39:789-797
34. Post RE, Carek PJ, Mainous Iii AG, Diaz VA, Johnson SP (2013) Factors affecting HPV vaccine use among recent family medicine residency graduates. Fam Med 45:90-94
35. Remes P, Selestine V, Changalucha J, Ross DA, Wight D, de Sanjosé S et al (2012) A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 30:5363-5367
36. Schnatz PF, Humphrey K, O'Sullivan DM (2010) Assessment of the perceptions and administration of the human papillomavirus vaccine. Low Genit Tract Dis 14:103-107
37. Trim K, Nagji N, Elit L, Roy K (2012) Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int 2012:921236
38. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R et al (2011) Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 years old girls are limited. Vaccine 29:8634-8641
39. Wong LP (2011) Issues surrounding HPV vaccine delivery in a multi-ethnic country in Asia: the physician's perspective. J Commun Health 36:14-22
40. Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW (2011) Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 24:380-385